CN102172369A - Chinese medicine for treating hepatocirrhosis - Google Patents

Chinese medicine for treating hepatocirrhosis Download PDF

Info

Publication number
CN102172369A
CN102172369A CN2010106120812A CN201010612081A CN102172369A CN 102172369 A CN102172369 A CN 102172369A CN 2010106120812 A CN2010106120812 A CN 2010106120812A CN 201010612081 A CN201010612081 A CN 201010612081A CN 102172369 A CN102172369 A CN 102172369A
Authority
CN
China
Prior art keywords
chinese medicine
treating
gram
nourishing
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010106120812A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2010106120812A priority Critical patent/CN102172369A/en
Publication of CN102172369A publication Critical patent/CN102172369A/en
Pending legal-status Critical Current

Links

Abstract

A Chinese medicine for treating hepatocirrhosis belongs to the field of Chinese medicines for treating digestive system diseases and aims to achieve good effect and fast response. The Chinese medicine is prepared from long stephania herb, ganoderma lucidum, angelica, pseudoginseng root, mulberry, testa trionidis and the like. The Chinese medicine has the functions of strengthening body immunity by treating the principal aspect of the disease, invigorating Qi and nourishing blood, nourishing the liver, softening and resolving hard masses, and promoting blood circulation to dispel blood stasis and alleviating pain and has the advantages of remarkable effect, definite efficacy and fast response.

Description

A kind of Chinese medicine for the treatment of liver cirrhosis
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The Chinese medicine that is used for the treatment of liver cirrhosis at present, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of liver cirrhosis patient constantly increases the weight of because of the fibrosis of liver, causes complication such as digestive tract hemorrhage, hepatic encephalopathy at last and death.Patient and family members thereof are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of liver cirrhosis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of liver cirrhosis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Lysimachiae 6-18 part Ganoderma 6-18 part Radix Angelicae Sinensis 6-18 part
Radix Notoginseng 3-9 part Fructus Mori 6-18 part Carapax Trionycis 6-18 part
The Chinese medicine of this treatment liver cirrhosis is made by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is as follows: Ganoderma is broken into graininess, cross 40 mesh sieves →, concentrate → mixed, leave standstill 10-12 hour, centrifugal → as to add 75% ethanol with 95% ethanol of 3 times of volumes with 1: 20 hot water (95 ℃) lixiviate → lixiviating solution decompression, precipitate polysaccharide → dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Herba Lysimachiae, Radix Angelicae Sinensis, Fructus Mori, Carapax Trionycis are extracted through conventional water extraction process, make extract extractum fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, make Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think in research, hypoimmunity, and positive QI-insufficiency is the deciding factor that hepatic fibrosis, liver cirrhosis development take place and lapse to.So this disease " refractory " is referred to as " persistent ailment ", so effect " humble ", obstinate, the underlying cause just are the decisive role to immunity of organisms (setting upright), and not enough on the understanding, dynamics is also little.In view of the above, the present invention attaches most importance to set upright, and in conjunction with the pathological characters of liver cirrhosis behind the liver cirrhosis especially viral hepatitis, adopts the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, hard masses softening and resolving is obtained remarkable result.The significance outstanding behaviours of this curative effect is aspect two: the one, and " dull pain in liver " that is difficult to overcome obviously alleviated, even complete obiteration; The 2nd, " the hepatic fibrosis reverse " that is difficult to realize realizes substantially or fully.Ganoderma, Fructus Mori the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, tonification the five internal organs, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng blood-nourishing blood-generating, promoting blood circulation, removing blood stasis and relieving pain, nourishing the liver easing the affected liver; 5 with the Herba Lysimachiae eliminating damp-heat, and treating stranguria, detumescence is to suppress hepatic ascites; Carapax Trionycis tonifying YIN and heat extraction, removing blood stasis and hard masses softening and resolving are to alleviate hepatic fibrosis.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, nourishing the liver easing the affected liver, and hard masses softening and resolving, the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Lysimachiae 70 kairine sesames 70 gram Radix Angelicae Sinensis 70 grams
Radix Notoginseng 30 gram Fructus Moris 70 gram Carapax Trionycis 70 grams
Weight is extracted Ganoderma with decoction and alcohol sedimentation technique in accordance with regulations; With conventional water extraction process Herba Lysimachiae, Radix Angelicae Sinensis, Fructus Mori, Carapax Trionycis are extracted, make extract fine powder 70 grams altogether, Radix Notoginseng is ground into fine powder, mix with said extracted thing fine powder, stir, make fine particle, the capsule of packing into No. 0, make 357 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Herba Lysimachiae 120 kairine sesames 120 gram Radix Angelicae Sinensis 120 grams
Radix Notoginseng 50 gram Fructus Moris 120 gram Carapax Trionycis 120 grams
By above-mentioned same method, make 607 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Herba Lysimachiae 180 kairine sesames 180 gram Radix Angelicae Sinensis 180 grams
Radix Notoginseng 80 gram Fructus Moris 180 gram Carapax Trionycis 180 grams
By above-mentioned same method, make 928 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
9 parts of 9 parts of Radix Angelicae Sinensis of 9 portions of Ganodermas of Herba Lysimachiae
9 parts of 9 parts of Carapax Trionycis of 4 portions of Fructus Moris of Radix Notoginseng
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
16 parts of 16 parts of Radix Angelicae Sinensis of 16 portions of Ganodermas of Herba Lysimachiae
16 parts of 16 parts of Carapax Trionycis of 7 portions of Fructus Moris of Radix Notoginseng
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science liver cirrhosis, through 9 routine clinical observations.Selecting the tcm diagnosis liver cirrhosis is standard: limb is soft weak, and is weak from head to foot; Abdominal distention, nauseating, upper abdomen dull pain; Hepatomegaly, quality are hard partially; Jaundice, anemia or bleeding tendency is arranged; Liver palm, spider angioma, cutaneous pigmentation and edema etc. appear.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 5 examples, women's 4 examples do not have other serious disease, and the age is 53 years old-82 years old, 67.4 years old mean age.
Efficacy determination:
1, produce effects: weak disappearance, limbs are strong; Abdominal distention, feel sick, upper abdomen dull pain obviously alleviates; Anemia and hepatic face are obviously alleviated, and face is pale, occur ruddy; Edema disappears; Hepatic fibrosis inspection index is obviously alleviated.
2, effective: on one's body energetically; Abdominal distention, feel sick, vomiting, anemia, edema etc. alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.9 philtrums of clinical experiment, produce effects 4 people, effective 4 people, invalid 1 people, total effective rate 88.8%.

Claims (1)

1. Chinese medicine for the treatment of liver cirrhosis, it is characterized in that: it is to make with the component of following weight ratio: Herba Lysimachiae 6-18 part, Ganoderma 6-18 part, Radix Angelicae Sinensis 6-18 part, Radix Notoginseng 3-9 part, Fructus Mori 6-18 part, Carapax Trionycis 6-18 part.
CN2010106120812A 2010-12-20 2010-12-20 Chinese medicine for treating hepatocirrhosis Pending CN102172369A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010106120812A CN102172369A (en) 2010-12-20 2010-12-20 Chinese medicine for treating hepatocirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010106120812A CN102172369A (en) 2010-12-20 2010-12-20 Chinese medicine for treating hepatocirrhosis

Publications (1)

Publication Number Publication Date
CN102172369A true CN102172369A (en) 2011-09-07

Family

ID=44515744

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010106120812A Pending CN102172369A (en) 2010-12-20 2010-12-20 Chinese medicine for treating hepatocirrhosis

Country Status (1)

Country Link
CN (1) CN102172369A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102389462A (en) * 2011-09-16 2012-03-28 北京绿源求证科技发展有限责任公司 Chinese medicine for treating cirrhosis
CN102614257A (en) * 2012-03-31 2012-08-01 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treatment of cirrhosis
CN102626445A (en) * 2012-04-20 2012-08-08 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating cirrhosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101112589A (en) * 2007-07-30 2008-01-30 牛昱翔 Liver-boosting calculus-discharging Chinese traditional medicine
CN101843773A (en) * 2009-10-22 2010-09-29 北京绿源求证科技发展有限责任公司 Chinese medicament for treating liver cirrhosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101112589A (en) * 2007-07-30 2008-01-30 牛昱翔 Liver-boosting calculus-discharging Chinese traditional medicine
CN101843773A (en) * 2009-10-22 2010-09-29 北京绿源求证科技发展有限责任公司 Chinese medicament for treating liver cirrhosis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102389462A (en) * 2011-09-16 2012-03-28 北京绿源求证科技发展有限责任公司 Chinese medicine for treating cirrhosis
CN102614257A (en) * 2012-03-31 2012-08-01 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treatment of cirrhosis
CN102626445A (en) * 2012-04-20 2012-08-08 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating cirrhosis

Similar Documents

Publication Publication Date Title
CN101843773B (en) Chinese medicament for treating liver cirrhosis
CN102048831A (en) Traditional Chinese medicine for treating cirrhosis
CN102114074A (en) Traditional Chinese medicine for treating diabetic diarrhea
CN102138969A (en) Traditional Chinese medicine for treating diabetic diarrhea
CN102172374A (en) Traditional Chinese medicine for treating hyperplasia of prostate
CN102172369A (en) Chinese medicine for treating hepatocirrhosis
CN102091130A (en) Traditional Chinese medicine for treating liver cirrhosis
CN102379924A (en) Traditional Chinese medicine for treating liver cirrhosis
CN101972349A (en) Traditional Chinese medicine for treating benign prostatic hyperplasia
CN102068529A (en) Traditional Chinese medicine for treatment of prostatic hyperplasia
CN102068569A (en) Traditional Chinese medicine for treating cirrhosis
CN101953893A (en) Traditional Chinese medicine for treating cirrhosis
CN102114080A (en) Traditional Chinese medicine for treating cirrhosis
CN102302558A (en) Chinese medicament for treating hepatocirrhosis
CN102389482A (en) Traditional Chinese medicine for treating cirrhosis
CN102138983A (en) Traditional Chinese medicine for treating hepatocirrhosis
CN101966230A (en) Traditional Chinese medicine for treating cirrhosis
CN101953891A (en) Chinese medicament for treating hepatocirrhosis
CN102389462A (en) Chinese medicine for treating cirrhosis
CN101991652A (en) Traditional Chinese medicine for treating liver cirrhosis
CN102670725A (en) Traditional Chinese medicine for curing cirrhosis
CN102389461A (en) Traditional Chinese medicine for treating cirrhosis
CN102379923A (en) Traditional Chinese medicine for treating cirrhosis
CN101843879B (en) Chinese medicament for treating liver cirrhosis
CN101874865B (en) Traditional Chinese medicine for treating cirrhosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110907